Phytotherapy for prostatism

References

• Darzynkiewicz Z, Traganos F, Wu JM, Chen S. Chinese herbal mixture PC SPES in treatment of prostate cancer [Review]. Int J Oncol 2000;17:729–36
   PubMed Web of Science ®Google Scholar
• Wang BX. Modern Pharmacology of Chinese Tradi- tional Medicine. Tianjin, China: Tianjin Science & Technology Publisher, 1997
   Google Scholar
• Kuo JM, Yeh DB, Pan BS. Rapid photometric assay evaluating antioxidative activity in edible plant material. J Agric Food Chem 1999;47:3206–9
   PubMed Web of Science ®Google Scholar
• Akihisa T, Yasukawa K, Oinuma H, Kasahara Y, Yamanouchi S, Takido M, et al. Triterpene alcohols from the flowers of compositae and their anti-inflammatory effects. Phytochemistry 1996;43:1255–60
   PubMed Web of Science ®Google Scholar
• Wang HK, Xia Y, Yang ZY, Natschke SL, Lee KH. Recent advances in the discovery and development of flavonoids and their analogues as antitumor and anti-HIV agents. Adv Exp Med Biol 1998;439:191–225
   PubMed Web of Science ®Google Scholar
• Xu YM, Lu PC. Experimental studies on immuno- stimulatory effects of the Isatis indigotica poly- saccharide. J Combined Traditional Chinese and Western Med 1991;11:357–9
   Google Scholar
• Qin GW, Xu RS. Recent advances on bioactive natural products from Chinese medicinal plants. Med Res Rev 1998;18:375–82
   PubMed Web of Science ®Google Scholar
• Li W, Asada Y, Yoshikawa T. Flavonoid constitu- ents from Glycyrrhiza glabra hairy root cultures. Phytochemistry 2000;55:447–56
   PubMed Web of Science ®Google Scholar
• Trovato A, Monforte MT, Rossitto A, Forestieri AM. In vitro cytotoxic effect of some medicinal plants containing flavonoids. Boll Chim Farm 1996; 135:263–6
   PubMedGoogle Scholar
• Agarwal R, Wang ZY, Mukhtar H. Inhibition of mouse skin tumor-initiating activity of DMBA by chronic oral feeding of glycyrrhizin in drinking water. Nutr Cancer 1991;15:187–93
   PubMed Web of Science ®Google Scholar
• Belinky PA, Aviram M, Mahmood S, Vaya J. Structural aspects of the inhibitory effect of glabridin on LDL oxidation. Free Radic Biol Med 1998;24:1419–29
   PubMed Web of Science ®Google Scholar
• Konovalova GG, Tikhaze AK, Lankin VZ. Anti- oxidant activity of parapharmaceutics containing natural inhibitors of free radical processes. Bull Exp Biol Med 2000;130:658–60
   PubMedGoogle Scholar
• Nose M, Terawaki K, Oguri K, Ogihara Y, Yoshimatsu K, Shimomura K. Activation of macrophages by crude polysaccharide fractions obtained from shoots of Glycyrrhiza glabra and hairy roots of Glycyrrhiza uralensis in vitro. <i>Biol Pharm Bull1998;21:1110–12
   Google Scholar
• Kroes BH, Beukelman CJ, van den Berg AJ, Wolbink GJ, van Dijk H, Labadie RP. Inhibition of human complement by beta-glycyrrhetinic acid. Immunology 1997;90:115–20
   PubMed Web of Science ®Google Scholar
• Shimizu N, Tomoda M, Satoh M, Gonda R, Ohara N. Characterization of a polysaccharide having activity on the reticuloendothelial system from the stolon of Glycyrrhiza glabra. Chem Pharm Bull (Tokyo) 1991;39:2082–6
   PubMedGoogle Scholar
• Francischetti IM, Monteiro RQ, Guimaraes JA, Francischetti B. Identification of glycyrrhizin as a thrombin inhibitor. Biochem Biophys Res Commun 1997;235:259–63
   PubMed Web of Science ®Google Scholar
• Badam L. In vitro antiviral activity of indigenous glycyrrhizin, licorice and glycyrrhizic acid on Japanese encephalitis virus. J Commun Dis 1997; 29:91–9
   PubMedGoogle Scholar
• Li W, Asada Y, Yoshikawa T. Antimicrobial flavonoids from Glycyrrhiza glabra hairy root cultures. Planta Med 1998;64:746–7
   PubMedGoogle Scholar
• Trovato A, Monforte MT, Forestieri AM, Pizzimenti F. In vitro anti-mycotic activity of some medicinal plants containing flavonoids. Boll Chim Farm 2000;139:225–7
   PubMedGoogle Scholar
• Miyasaka K, Hiramatsu Y, Takezaki T. Pharmaco- logical studies of lycorenine, an alkaloid of Lycoris radiata: vasodepressor mechanism in rats. Jpn J Pharmacol 1979;29:605–22
   PubMedGoogle Scholar
• Rafi MM, Rosen RT, Vassil A, Ho CT, Zhang H, Ghai G, et al. Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid. Anticancer Res 2000;20:2653–8
   PubMed Web of Science ®Google Scholar
• Zhu HS, Yang XL, Wang LB, Zhao DX, Chen L. Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on HeLa cells. Cell Biol Toxicol 2000;16:201–6
   PubMed Web of Science ®Google Scholar
• Min BS, Gao JJ, Nakamura N, Hattori M. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull (Tokyo) 2000;48:1026–33
   PubMed Web of Science ®Google Scholar
• Wang SY, Hsu ML, Hsu HC Tzeng CH, Lee SS, Shiao MS, et al. The antitumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer 1997;70:699–705
   PubMed Web of Science ®Google Scholar
• Eo SK, Kim YS, Lee CK, Han SS. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. J Ethnopharmacol 1999;68:129–36
   PubMed Web of Science ®Google Scholar
• Murasugi A, Tanaka S, Komiyama N, Iwata N, Kino K, Tsunoo H, et al. Molecular cloning of a cDNA and a gene encoding an immuno- modulatory protein, Ling Zhi-8, from a fungus, Ganoderma lucidum. J Biol Chem 1991;266:2486–93
   PubMed Web of Science ®Google Scholar
• Lee JM, Kwon H, Jeong H, Lee JW, Lee SY, Baek SJ, et al. Inhibition of lipid peroxidation and oxida- tive DNA damage by Ganoderma lucidum. Phytother Res 2001;15:245–9
   PubMed Web of Science ®Google Scholar
• Lee SY, Rhee HM. Cardiovascular effects of myce- lium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypo- tensive action. Chem Pharm Bull (Tokyo) 1990; 38:1359–64
   PubMed Web of Science ®Google Scholar
• Morigiwa A, Kitabatake K, Fujimoto Y, Ikekawa N. Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chem Pharm Bull (Tokyo) 1986;34:3025–8
   PubMed Web of Science ®Google Scholar
• Chiu WT, Chan P, Liao SS, Liou JR, Cheng JT. Effect of trilinolein on the activity and gene expres- sion of superoxide dismutase in cultured rat brain astrocytes. Neurosci Lett 1999;2;269:17–20
   PubMedGoogle Scholar
• Smith RE, Donachie AM, Mowat AM. Immune stimulating complexes as mucosal vaccines. Immunol Cell Biol 1998;76:263–9
   PubMed Web of Science ®Google Scholar
• Chan P, Niu CS, Tomlinson B, Hong CT, Chen JP, Hong CY, et al. Effect of trilinolein on super- oxide dismutase activity and left ventricular pres- sure in isolated rat hearts subjected to hypoxia and normoxic perfusion. Pharmacology 1997;55:252–8
   PubMedGoogle Scholar
• Chan P, Niu CS, Cheng JT, Tsao CW, Tsai SK, Hong CY. Trilinolein preserves mitochondria ultrastructure in isolated rat heart subjected to global ischemia through antioxidant activity as measured by chemiluminescence. Pharmacology 1996;52:216–25
   PubMedGoogle Scholar
• Wang RL, Gao BL, Xiong ML, Mei QD, Fan KS, Zuo ZK, et al. Potentiation by Rabdosia rubescens on chemotherapy of advanced esophageal carcinoma. Chinese J Tumor 1986;8:297–9
   Google Scholar
• Wang RL. A report of 40 cases of esophageal carci- noma surviving for more than 5 years after drug treatment. Chinese J Tumor 1993;15:300–2
   Google Scholar
• Gao ZG, Ye QX, Zhang TM. Synergistic effect of oridonin and cisplatin on cytotoxicity and DNA cross-link against mouse sarcoma S180 cells in culture. Chinese J Pharmacol 1993;14:561–4
   Google Scholar
• Wilt TJ, Ishani A, Rutks I, MacDonald R. Phyto- therapy for benign prostatic hyperplasia. Publ Health Nutr 2000;3:459–72
   PubMedGoogle Scholar
• Chan FL, Choi HL, Chen ZY, Chan PS, Huang Y. Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin. Cancer Lett 2000;160:219–28
   PubMed Web of Science ®Google Scholar
• Razina TG, Zueva EP, Amosova EN, Krylova SG. Medicinal plant preparations used as adjuvant therapeutics in experimental oncology. Eksp Klin Farmakol 2000;63:59–61
   PubMedGoogle Scholar
• Gol’dberg VE, Ryzhakov VM, Matiash MG, Stepovaia EA, Boldyshev DA, Litvinenko VI, et al. Dry extract of Scutellaria baicalensis as a hemo- stimulant in antineoplastic chemotherapy in patients with lung cancer. Eksp Klin Farmakol 1997; 60:28–30
   PubMedGoogle Scholar
• Smol’ianinov ES, Gol’dberg VE, Matiash MG, Ryzhakov VM, Boldyshev DA, Litvinenko VI, et al. Effect of Scutellaria baicalensis extract on the immunologic status of patients with lung cancer receiving antineoplastic chemotherapy. Eksp Klin Farmakol 1997;60:49–51
   PubMedGoogle Scholar
• Shieh DE, Liu LT, Lin CC. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res 2000;20:2861–5
   PubMed Web of Science ®Google Scholar
• Sook Chi Y, Sun Cheon B, Pyo Kim H. Effect of wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in lipopolysaccharide-treated RAW 264.7 cells. Biochem Pharmacol 2001;61:1195–203
   PubMedGoogle Scholar
• Gao Z, Huang K, Yang X, Xu H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim Biophys Acta 1999;1472:643–50
   PubMed Web of Science ®Google Scholar
• Shao ZH, Li CQ, Vanden Hoek TL, Becker LB, Schumacker PT, Wu JA, et al. Extract from Scutellaria baicalensis Georgi attenuates oxidant stress in cardiomyocytes. J Mol Cell Cardiol 1999;31:1885–95
   PubMed Web of Science ®Google Scholar
• Gao Z, Huang K, Xu H. Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxida- tive stress in HS-SY5Y cells. Pharmacol Res 2001; 43:173–8
   PubMed Web of Science ®Google Scholar
• Huang RL, Chen CC, Huang HL, Chang CG, Chen CF, Chang C, et al. Anti-hepatitis B virus effects of wogonin isolated from Scutellaria baicalensis. Planta Med 2000;66:694–8
   Google Scholar
• Li BQ, Fu T, Yan YD, Baylor NW, Ruscetti FW, Kung HF. Inhibition of HIV infection by baicalin – a flavonoid compound purified from Chinese herbal medicine. Cell Mol Biol Res 1993;39:119–24
   PubMedGoogle Scholar
• Wu JA, Attele AS, Zhang L, Yuan CS. Anti-HIV activity of medicinal herbs: usage and potential development. Am J Chin Med 2001;29:69–81
   PubMed Web of Science ®Google Scholar
• Li BQ, Fu T, Dongyan Y, Mikovits JA, Ruscetti FW, Wang JM. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. Biochem Biophys Res Commun 2000;276:534–8
   PubMed Web of Science ®Google Scholar
• Porterfield H. UsToo PC-SPES surveys: review of studies and update of previous survey results. Mol Urol 2000;4:289–91
   PubMedGoogle Scholar
• PC-SPES Patient Survey 2000/2001 at www.rootsandsprouts.com/ustoosurvey.htm
   Google Scholar
• Oh WK, George DJ, Hackmann K, Manola J, Kantoff PW. Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer. Urology 2001;57:122–6
   PubMed Web of Science ®Google Scholar
• Pfeifer BL, Pirani JF, Hamann SR, Klippel KF. PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer. BJU Int 2000;85:481–5
   PubMed Web of Science ®Google Scholar
• de la Taille A, Hayek OR, Burchardt M, Burchardt T, Katz AE. Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports. J Altern Complement Med 2000;6:449–51
   PubMed Web of Science ®Google Scholar
• Small EJ, Frohlich MW, Bok R, Shinohara K, Grossfeld G, Rozenblat Z, et al. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol 2000; 18:3595–603
   PubMed Web of Science ®Google Scholar
• Tiwari RK, Geliebter J, Garikapaty VP, Yedavelli SP, Chen S, Mittelman A. Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer. Int J Oncol 1999;14:713–9
   PubMed Web of Science ®Google Scholar
• de la Taille A, Buttyan R, Hayek O, Bagiella E, Shabsigh A, Burchardt M, et al. Herbal therapy PC-SPES: in vitro effects and evaluation of its effi- cacy in 69 patients with prostate cancer. J Urol 2000;164:1229–34
   PubMed Web of Science ®Google Scholar
• Kubota T, Hisatake J, Hisatake Y, Said JW, Chen SS, Holden S, et al. PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo. Prostate 2000;42:163–71
   Google Scholar
• de la Taille A, Hayek OR, Buttyan R, Bagiella E, Burchardt M, Katz AE. Effects of a phyto- therapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients. BJU Int 1999;84:845–50
   PubMed Web of Science ®Google Scholar
• Hsieh T, Chen SS, Wang X, Wu JM. Regulation of androgen receptor and prostate specific antigen expression in the androgen-responsive human prostate LNCaP cells by the Chinese herbal prepa- ration, PC-SPES. Biochem Mol Biol Int 1997;42:535–44
   PubMedGoogle Scholar
• Halicka HD, Ardelt B, Juan G, et al. Apoptosis and cell cycle effects induced by extracts of the Chinese herbal preparation PC-SPES. Int J Oncol 1997;11:437–48
   PubMed Web of Science ®Google Scholar
• Hsieh TC, Ng C, Chang CC, Chen SS, Mittleman A, Wu JM. Induction of apoptosis and down- regulation of bcl-6 in mutu I cells treated with ethanolic extracts of the Chinese herbal supplement PC-SPES. Int J Oncol 1998;13:1199–202
   PubMed Web of Science ®Google Scholar
• DiPaola RS, Zhang H, Lambert GH, Meeker R, Licitra E, Rafi MM, et al. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med 1998; 339:785–91
   PubMed Web of Science ®Google Scholar
• Wilt TJ, Ishani A, Stark G, MacDonald R, Lau J, Mulrow C. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. J Am Med Assoc 1998;280:1604–9
   PubMed Web of Science ®Google Scholar
• Gerber GS. Saw palmetto for the treatment of men with lower urinary tract symptoms. J Urol 2000; 163:1408–12
   PubMed Web of Science ®Google Scholar
• Gerber GS, Zagaja GP, Bales GT, Chodak GW, Contreras BA. Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms. Urology 1998;51:1003–7
   PubMed Web of Science ®Google Scholar
• Sokeland J. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome. BJU Int 2000;86:439–42
   PubMedGoogle Scholar
• Marks LS, Partin AW, Epstein JI, Tyler VE, Simon I, Macairan ML, et al. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. J Urol 2000;163:1451–6
   PubMed Web of Science ®Google Scholar
• Iehle C, Delos S, Guirou O, Tate R, Raynaud JP, Martin PM. Human prostatic steroid 5 alpha- reductase isoforms – a comparative study of selec- tive inhibitors. J Steroid Biochem Mol Biol 1995; 54:273–9
   PubMed Web of Science ®Google Scholar
• Breu W, Hagenlocher M, Redl K, Tittel G, Stadler F, Wagner H. Anti-inflammatory activity of sabal fruit extracts prepared with supercritical carbon dioxide. In vitro antagonists of cyclooxygenase and 5-lipoxygenase metabolism. Arzneimittelforschung 1992;42:547–51
   PubMed Web of Science ®Google Scholar
• Wagner H, Proksch A, Riess-Maurer I, Vollmar A, Odenthal S, Stuppner H, et al. Immunostimulant action of polysaccharides (heteroglycans) from higher plants. Preliminary communication. Arzneimittelforschung 1984;34:659–61
   PubMed Web of Science ®Google Scholar
• Goepel M, Dinh L, Mitchell A, Schafers RF, Rubben H, Michel MC. Do saw palmetto extracts block human alpha1-adrenoceptor subtypes in vivo? Prostate 2001;15;46:226–32
   PubMedGoogle Scholar
• MacDonald R, Ishani A, Rutks I, Wilt TJ. A systematic review of Cernilton for the treatment of benign prostatic hyperplasia. BJU Int 2000;85:836–4
   PubMedGoogle Scholar
• Buck AC, Cox R, Rees RW, Ebeling L, John A. Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo- controlled study. Br J Urol 1990;66:398–404
   PubMedGoogle Scholar
• Zhang X, Habib FK, Ross M, Burger U, Lewenstein A, Rose K, et al. Isolation and charac- terization of a cyclic hydroxamic acid from a pollen extract, which inhibits cancerous cell growth in vitro. J Med Chem 1995;38:735–8
   PubMed Web of Science ®Google Scholar
• Habib FK, Ross M, Lewenstein A, Zhang X, Jaton JC. Identification of a prostate inhibitory substance in a pollen extract. Prostate 1995;26:133–9
   PubMed Web of Science ®Google Scholar
• Wojcicki J, Samochowiec L, Bartlomowicz B, Hinek A, Jaworska M, Gawronska-Szklarz B. Effect of pollen extract on the development of experimental atherosclerosis in rabbits. Atherosclero- sis 1986;62:39–45
   PubMedGoogle Scholar
• Wojcicki J, Samochowiec L, Kadlubowska D, Kownacka A. Study on the antioxidant properties of pollen extracts. Arch Immunol Ther Exp (Warsz) 1987;35:725–9
   PubMedGoogle Scholar
• Habib FK, Ross M, Buck AC, Ebeling L, Lewenstein A. In vitro evaluation of the pollen extract, cernitin T-60, in the regulation of prostate cell growth. Br J Urol 1990;66:393–7
   PubMedGoogle Scholar
• Yasumoto R, Kawanishi H, Tsujino T, Tsujita M, Nishisaka N, Horii A, et al. Clinical evaluation of long-term treatment using cernitin pollen extract in patients with benign prostatic hyperplasia. Clin Ther 1995;17:82–7
   PubMed Web of Science ®Google Scholar
• Yablonsky F, Nicolas V, Riffaud JP, Bellamy FA. Antiproliferative effect of Pygeum africanum extract on rat prostatic fibroblasts. J Urol 1997;157:2381–7
   PubMed Web of Science ®Google Scholar
• Ishani A, MacDonald R, Nelson D, Rutks I, Wilt TJ. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis. Am J Med 2000;109:654–64
   PubMed Web of Science ®Google Scholar
• Carani C, Salvioli V, Scuteri A, Borelli A, Baldini A, Granata AR, et al. Urological and sexual evalua- tion of treatment of benign prostatic disease using Pygeum africanum at high doses. Arch Ital Urol Nefrol Androl 1991;63:341–5
   PubMedGoogle Scholar
• Nicoletti M, Galeffi C, Messana I, Marini-Bettolo GB. Hypoxidaceae. Medicinal uses and the norlignan constituents. J Ethnopharmacol 1992;36:95–101
   PubMedGoogle Scholar
• Klippel KF, Hiltl DM, Schipp B. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. Br J Urol 1997;80:427–32
   PubMedGoogle Scholar
• Lichius JJ, Muth C. The inhibiting effects of Urtica dioica root extracts on experimentally induced pros- tatic hyperplasia in the mouse. Planta Med 1997;63:307–10
   PubMed Web of Science ®Google Scholar
• Konrad L, Muller HH, Lenz C, Laubinger H, Aumuller G, Lichius JJ. Antiproliferative effect on human prostate cancer cells by a stinging nettle root (Urtica dioica) extract. Planta Med 2000;66:44–7
   PubMed Web of Science ®Google Scholar
• Riehemann K, Behnke B, Schulze-Osthoff K. Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the proinflamma- tory transcription factor NF-kappaB. FEBS Lett 1999;442:89–94
   PubMedGoogle Scholar
• Carbin BE, Larsson B, Lindahl O. Treatment of benign prostatic hyperplasia with phytosterols. Br J Urol 1990;66:639–41
   PubMedGoogle Scholar
• Dreikorn K, Schonhofer PS. Status of phyto- therapeutic drugs in treatment of benign prostate hyperplasia. Urologe A 1995;34:119–29
   PubMedGoogle Scholar